969 related articles for article (PubMed ID: 11433374)
1. Alpha-synuclein and neurodegenerative diseases.
Goedert M
Nat Rev Neurosci; 2001 Jul; 2(7):492-501. PubMed ID: 11433374
[No Abstract] [Full Text] [Related]
2. Alpha-synuclein: normal function and role in neurodegenerative diseases.
Norris EH; Giasson BI; Lee VM
Curr Top Dev Biol; 2004; 60():17-54. PubMed ID: 15094295
[TBL] [Abstract][Full Text] [Related]
3. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
[TBL] [Abstract][Full Text] [Related]
4. [Alpha-synucleinopathies].
Ferrer I
Neurologia; 2001 Apr; 16(4):163-70. PubMed ID: 11412709
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy.
Nishie M; Mori F; Fujiwara H; Hasegawa M; Yoshimoto M; Iwatsubo T; Takahashi H; Wakabayashi K
Acta Neuropathol; 2004 Apr; 107(4):292-8. PubMed ID: 14722716
[TBL] [Abstract][Full Text] [Related]
6. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease.
Auluck PK; Chan HY; Trojanowski JQ; Lee VM; Bonini NM
Science; 2002 Feb; 295(5556):865-8. PubMed ID: 11823645
[TBL] [Abstract][Full Text] [Related]
7. Alpha synuclein in neurodegenerative disorders: murderer or accomplice?
Mezey E; Dehejia A; Harta G; Papp MI; Polymeropoulos MH; Brownstein MJ
Nat Med; 1998 Jul; 4(7):755-7. PubMed ID: 9662355
[No Abstract] [Full Text] [Related]
8. Neuropathological spectrum of synucleinopathies.
Jellinger KA
Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
[TBL] [Abstract][Full Text] [Related]
9. Alpha-synuclein and transgenic mouse models.
Fernagut PO; Chesselet MF
Neurobiol Dis; 2004 Nov; 17(2):123-30. PubMed ID: 15474350
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein pathology affecting Bergmann glia of the cerebellum in patients with alpha-synucleinopathies.
Piao YS; Mori F; Hayashi S; Tanji K; Yoshimoto M; Kakita A; Wakabayashi K; Takahashi H
Acta Neuropathol; 2003 Apr; 105(4):403-9. PubMed ID: 12624794
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
[TBL] [Abstract][Full Text] [Related]
12. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.
Giasson BI; Duda JE; Murray IV; Chen Q; Souza JM; Hurtig HI; Ischiropoulos H; Trojanowski JQ; Lee VM
Science; 2000 Nov; 290(5493):985-9. PubMed ID: 11062131
[TBL] [Abstract][Full Text] [Related]
13. alpha-Synuclein is phosphorylated in synucleinopathy lesions.
Fujiwara H; Hasegawa M; Dohmae N; Kawashima A; Masliah E; Goldberg MS; Shen J; Takio K; Iwatsubo T
Nat Cell Biol; 2002 Feb; 4(2):160-4. PubMed ID: 11813001
[TBL] [Abstract][Full Text] [Related]
14. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.
Spillantini MG; Crowther RA; Jakes R; Cairns NJ; Lantos PL; Goedert M
Neurosci Lett; 1998 Jul; 251(3):205-8. PubMed ID: 9726379
[TBL] [Abstract][Full Text] [Related]
15. Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions.
Popescu A; Lippa CF; Lee VM; Trojanowski JQ
Arch Neurol; 2004 Dec; 61(12):1915-9. PubMed ID: 15596612
[TBL] [Abstract][Full Text] [Related]
16. Synucleins in synaptic plasticity and neurodegenerative disorders.
Clayton DF; George JM
J Neurosci Res; 1999 Oct; 58(1):120-9. PubMed ID: 10491577
[TBL] [Abstract][Full Text] [Related]
17. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
Zarranz JJ; Alegre J; Gómez-Esteban JC; Lezcano E; Ros R; Ampuero I; Vidal L; Hoenicka J; Rodriguez O; Atarés B; Llorens V; Gomez Tortosa E; del Ser T; Muñoz DG; de Yebenes JG
Ann Neurol; 2004 Feb; 55(2):164-73. PubMed ID: 14755719
[TBL] [Abstract][Full Text] [Related]
18. Controversy: is Parkinson's disease a single disease entity? Yes.
Takahashi H; Wakabayashi K
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S31-7. PubMed ID: 15885626
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein.
Lotharius J; Brundin P
Nat Rev Neurosci; 2002 Dec; 3(12):932-42. PubMed ID: 12461550
[No Abstract] [Full Text] [Related]
20. alpha-synuclein and cytosolic dopamine: stabilizing a bad situation.
Sulzer D
Nat Med; 2001 Dec; 7(12):1280-2. PubMed ID: 11726961
[No Abstract] [Full Text] [Related]
[Next] [New Search]
